Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > Interesting post yesterday on.... ceo.ca ipa
View:
Post by wallpaper2 on Dec 30, 2021 2:09pm

Interesting post yesterday on.... ceo.ca ipa

Someone named Paul tweeted that Samsung "South Korean conglomerate"  is in negotiations to buy Biogen for $40 Billion dollars !!  Biogen are developing new drugs to treat the likes of Alzheimers, MS, ALS, Parkinsons etc. etc. and have 33 targets in their pipeline.  IPA have siome of those same targets in their 30 target pipeline  I read where.Samsung have set aside more than $100 Billion to invest in this sector. They believe this is where the  money will be made.  We will be hearing soon how IPA is progressing with those targets as well as their Covid and  Omicron. IPA wouldn't be wasting time and money working on these neurological disorders if they didn't feel their  approach could be successful. Try and wrap your head around the possibilities and potential we have with IPA. This could very well be a Billion$$ company in 2022.  I believe that Jennifer said  we would have more results and news coming in January..We also have the San Fransisco JP Morgan  conference in 2 weeks with one on one meetings with the worlds major Pharmas . Do you think the likes of Samsung and Biogen are aware of IPA now or soon will be?   I do.
Comment by wallpaper2 on Dec 31, 2021 11:39am
Samsung is denying the Korean report based on a interview from a senior official at a global Investment Bank. Biogen will not comment and their stock rose 9.5% on the report??  Biogen was in partnership with Samsung prior to this weeks news report in the "Korea Economic Daily." Samsung said in Sept 2021 they would invest $200 billion in Biopharmaceuticals, semi conductors, and AI ...more  
Comment by mercedesman on Dec 31, 2021 9:15pm
I think that throwing just one of those billions our way ( USD of course) would be a reasonable albeit speculative bet.  Good enough for a 12 bagger for us!  2022 will be their year! MM  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities